Gilead Sciences has agreed to acquire PepStar Therapeutics’ oral inflammation drug program for $1.275 billion, strengthening its efforts to develop treatments for …
France has reported the first human case of Shamonda virus, a pathogen previously detected in animals, raising new questions about its ability …
Wedgewood Pharmacy has announced a nationwide recall of its products involving nearly 4,000 listings of compounded veterinary medications over concerns that some …
Swedish investment firm EQT has agreed to acquire molecular diagnostics company QIAGEN in an all-cash takeover deal valued at approximately €9.6 billion …
A team of researchers from the University of Sydney has identified a potential new depression subtype linked to disruptions in the body’s …
The US Food and Drug Administration (FDA) approved GSK’s hepatitis B drug Hibsago (bepirovirsen), introducing a new treatment option for certain adults …
NSW Health has issued a warning about unapproved peptide products after new surveillance data recorded 1,180 emergency department presentations linked to peptide …
The U.S. Food and Drug Administration (FDA) has submitted a proposed interim policy to the White House that could make it easier …
India’s Mankind Pharma has agreed to acquire a 70% stake in Belgium-based biotechnology company Armed Cell Therapeutics B.V. (ACTx) for €48 million, …
The Centers for Medicare & Medicaid Services (CMS) is ending Affordable Care Act (ACA), commonly known as Obamacare, subsidies for approximately 189,000 …
The European Commission has approved Kimberly-Clark’s proposed $40 billion acquisition of Kenvue, the consumer health company behind brands such as Tylenol, on …
CVS Pharmacy and its related corporate entities have agreed to pay $315 million to resolve allegations that they unlawfully filled opioid prescriptions …
Gilead Sciences has agreed to acquire PepStar Therapeutics’ oral inflammation drug program for $1.275 billion, strengthening its efforts to develop
France has reported the first human case of Shamonda virus, a pathogen previously detected in animals, raising new questions about
Wedgewood Pharmacy has announced a nationwide recall of its products involving nearly 4,000 listings of compounded veterinary medications over concerns
Swedish investment firm EQT has agreed to acquire molecular diagnostics company QIAGEN in an all-cash takeover deal valued at approximately
A team of researchers from the University of Sydney has identified a potential new depression subtype linked to disruptions in
The US Food and Drug Administration (FDA) approved GSK’s hepatitis B drug Hibsago (bepirovirsen), introducing a new treatment option for
NSW Health has issued a warning about unapproved peptide products after new surveillance data recorded 1,180 emergency department presentations linked
The U.S. Food and Drug Administration (FDA) has submitted a proposed interim policy to the White House that could make
India’s Mankind Pharma has agreed to acquire a 70% stake in Belgium-based biotechnology company Armed Cell Therapeutics B.V. (ACTx) for
The Centers for Medicare & Medicaid Services (CMS) is ending Affordable Care Act (ACA), commonly known as Obamacare, subsidies for
The European Commission has approved Kimberly-Clark’s proposed $40 billion acquisition of Kenvue, the consumer health company behind brands such as
CVS Pharmacy and its related corporate entities have agreed to pay $315 million to resolve allegations that they unlawfully filled
